S (continued)
- SR-29142
- SR-45023A
- SR49059
- SRS
- SSG
- SSRI
- St. Benedict's thistle
- St. John's wort
- ST1481
- stable disease
- stage 0 anal carcinoma in situ
- stage 0 bladder carcinoma in situ
- stage 0 breast carcinoma in situ
- stage 0 cervical carcinoma in situ
- stage 0 chronic lymphocytic leukemia
- stage 0 colorectal carcinoma in situ
- stage 0 disease
- stage 0 esophageal carcinoma in situ
- stage 0 extrahepatic bile duct carcinoma in situ
- stage 0 gallbladder carcinoma in situ
S (continued)
- stage 0 gastric carcinoma in situ
- stage 0 hypopharyngeal carcinoma in situ
- stage 0 laryngeal carcinoma in situ
- stage 0 lip and oral cavity carcinoma in situ
- stage 0 maxillary sinus carcinoma in situ
- stage 0 medullary thyroid carcinoma in situ
- stage 0 melanoma
- stage 0 Merkel cell carcinoma in situ
- stage 0 nasal cavity and ethmoid sinus carcinoma in situ
- stage 0 nasopharyngeal carcinoma in situ
- stage 0 non-small cell lung carcinoma in situ
- stage 0 nonmelanoma skin carcinoma in situ
- stage 0 oropharyngeal carcinoma in situ
- stage 0 pancreatic carcinoma in situ
- stage 0 penile carcinoma in situ
- stage 0 testicular carcinoma in situ
- stage 0 transitional cell carcinoma in situ of the renal pelvis and ureter
- stage 0 urethral carcinoma in situ
- stage 0 vaginal carcinoma in situ
- stage 0 vulvar carcinoma in situ